Karen Smith

@karensmithfl

Investor/ Swing Trader $ACHR LT investor

+ Follow

imet33

@imetelstat

$GERN #IMETELSTAT #WINNING - - -not affiliated with Geron

+ Follow

Adam Feuerstein ✡️

@adamfeuerstein

Biotech reporter @statnews. Dog ❤️er. Polk Award winner. #COYS. Said one analyst: The likes of Adam Feuerstein attack viciously. On Signal: stataf.54

+ Follow

Rigel Pharmaceuticals

@rigelpharma

Rigel is a biotech company dedicated to discovering, developing and providing novel therapies for hematologic disorders and cancer.

+ Follow

Liz Chang

@lizkchang

Always looking to point out the obvious.

+ Follow

Claudia Bruedigam

@cbruedigam

+ Follow

Ryan Burr

@ryanburr

Big 10 Network Hoops. PGA Tour Live. Owner NB3JGNC. Entrepreneur! A-Game Sports drink & Cuse Alum

+ Follow

Mikkael A. Sekeres MD, MS

@mikkaelsekeres

Chief, Division of Hematology @SylvesterCancer @UMiamiHealth | Clinical scientist, essayist | Author @mitpress | Chair @ASH_hematology Communications | My views

+ Follow

Eric Rosenthal

@ericsports

Sports analyst. Fmr: Founder Page2Sports. Fmr: @DraftKings 🏀 & 🏈 Coach. Podcaster. Jokes. Travel. IG @ NFLTrashTalkers

+ Follow

Brent

@bin2gray

Here mostly for investing ideas, rarely have my own, crib from others. A sucker for biotech. Sometimes I hate on Trump so stay away if that offends.

+ Follow

Rami komrokji

@ramikomrokji

+ Follow

Ruben A. Mesa, MD

@mpdrc

President Atrium Health Levine Cancer & Exec Director AH Wake Forest Baptist Comprehensive Cancer Center. #MPNs (Tweets-My Opinion)

+ Follow

Paul

@lipa0902

Tweets are my personal opinion, not advice to anyone. I try to be honest and accurate, but can be wrong. Likes/Retweets are not endorsement.

+ Follow

Ron Reblando

@ronreblando

Finance, Aerospace & Defense. Board of Directors, Cincinnati Hispanic Chamber of Commerce. Pomona College. MBA, Yale University.

+ Follow

David Steensma, MD

@davidsteensma

Hematologist-oncologist. @AjaxThx CMO. Former Edward P. Evans Chair in MDS @DanaFarber, @HarvardMed & @MayoClinic faculty, @NovartisScience hematology head.

+ Follow

Tara Bancroft

@tarabancroft

PhD from Yale. Analyst in Healthcare/Biotech. Published expert in vaccine immunology. Wife of a US Navy veteran.

+ Follow

Andrew Kuykendall MD

@kuykendallmd

Assistant Member, Malignant Hematology at H. Lee Moffitt Cancer Center - All tweets are my own opinions/thoughts

+ Follow

Uwe Platzbecker

@uweplatzbecker

+ Follow

Charlie Plattus

@zipcharlie

🇺🇸Creator of ZipTrader - we publish research & commentary on the economy and trade ideas. Not financial advice. Always do your own due diligence.

+ Follow

Candel Therapeutics

@candeltx

Candel Therapeutics an off-the-shelf multimodal biological immunotherapy company empowering the patient's immune system to fight cancer.

+ Follow

Amer Zeidan MBBS,MHS ‏عامر زيدان

@dr_amerzeidan

Professor of Medicine, Chief of Hematologic Malignancies, Director of Heme Clinical Research @Yale. #Madridista. #AMLsm & #MDSsm. COI bit.ly/2YfwJ9V

+ Follow

BioPharm_the_Magnificent

@crypto_biotech

BioPharma 10x Engineer. Full Time Trader/Investor. $LUCD $ARDX $GLSI $VKTX 95% of Positions. Not Investment Advice. Do your own Research.

+ Follow

Kien Le

@kienle46050241

I like cars

+ Follow

DL

@gapboy416

+ Follow

Ardelyx

@ardelyx

Translating Scientific Breakthroughs into Promise for Patients. Community Guidelines: rb.gy/07ltg3

+ Follow

Steve Lane

@stevenlane_qimr

Leukaemia research, QIMR. Consultant Haematologist, RBWH. President of Haematology Soc Aust and NZ. Comments/opinions are my own

+ Follow

Sdrawkcabeman

@_sdrawkcabeman_

About 90% of all cancers require telomerase. A telomerase inhibitor, such as Imetelstat, can potentially be used across the spectrum of cancers.

+ Follow